Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12

Pu Feng1, Joseph J Meissler, Martin W Adler

  • 1Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.

Insights

Morphine withdrawal dramatically increases sepsis (LPS) lethality in mice. This heightened mortality is linked to elevated tumor necrosis factor-alpha (TNF-alpha) and nitric oxide, suggesting TNF-alpha inhibition as a protective strategy.

Area of Science:

  • Immunology
  • Pharmacology
  • Toxicology

Background:

  • Opioid dependence is a significant public health issue.
  • Opioid withdrawal can trigger complex physiological changes.
  • Sepsis, often caused by bacterial lipopolysaccharide (LPS), is a life-threatening condition.

Purpose of the Study:

  • To investigate the impact of morphine withdrawal on susceptibility to lipopolysaccharide (LPS)-induced lethality.
  • To elucidate the immunological mechanisms underlying this heightened susceptibility.

Main Methods:

  • Morphine dependence was induced in mice using slow-release pellets over 96 hours.
  • Animals were withdrawn from morphine or placebo, followed by administration of LPS or saline.
  • Serum levels of TNF-alpha, nitric oxide, and IL-12 were measured.
  • The effect of anti-TNF-alpha antibody treatment was assessed.

Main Results:

  • Morphine-withdrawn mice challenged with LPS exhibited 100% mortality.
  • Control groups (placebo withdrawal + LPS, morphine withdrawal + saline) survived.
  • LPS-treated, morphine-withdrawn mice showed elevated serum TNF-alpha and nitric oxide, and reduced IL-12.
  • Anti-TNF-alpha antibody administration significantly protected morphine-withdrawn mice from LPS lethality.

Conclusions:

  • Morphine withdrawal sensitizes mice to LPS-induced lethality.
  • Elevated TNF-alpha production during morphine withdrawal is a key mediator of this sensitization.
  • Targeting TNF-alpha may offer a therapeutic approach to mitigate sepsis mortality in opioid-dependent individuals undergoing withdrawal.